Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fuchs

Showing results (661-670 of 917) with videos related to

Pageof 92
Sort By:
Journal of Human Hypertension|April 7, 2006
Absence of association between depression and hypertension: results of a prospectively designed population-based studyM Wiehe, S C Fuchs, L B Moreira, et al.
Klinische Wochenschrift|December 1, 1978
[Calcium and phosphate metabolism in hemofiltration (author's transl)]C Fuchs, D Dorn, H V Henning, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.
BMC Gastroenterology|July 13, 2010
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorTsutomu Fujii, Bryan C Fuchs, Suguru Yamada, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Radiologic Clinics of North America|May 23, 1998
Interventional radiology with laser in bone and jointA Gangi, J L Dietemann, B Gasser, et al.
Annals of Internal Medicine|December 16, 1998
Postmenopausal hormone use and risk for colorectal cancer and adenomaF Grodstein, M E Martinez, E A Platz, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.
Pageof 92

Showing results (661-670 of 917) with videos related to

Sort By:
Pageof 92
Journal of Human Hypertension|April 7, 2006
Absence of association between depression and hypertension: results of a prospectively designed population-based studyM Wiehe, S C Fuchs, L B Moreira, et al.
Klinische Wochenschrift|December 1, 1978
[Calcium and phosphate metabolism in hemofiltration (author's transl)]C Fuchs, D Dorn, H V Henning, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.
BMC Gastroenterology|July 13, 2010
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorTsutomu Fujii, Bryan C Fuchs, Suguru Yamada, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Radiologic Clinics of North America|May 23, 1998
Interventional radiology with laser in bone and jointA Gangi, J L Dietemann, B Gasser, et al.
Annals of Internal Medicine|December 16, 1998
Postmenopausal hormone use and risk for colorectal cancer and adenomaF Grodstein, M E Martinez, E A Platz, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.
Pageof 92